A novel, antibody-based radiopharmaceutical for advanced thyroid cancer
– Published 25 May 2022
![Icon of a thyroid gland.](/fileadmin/immun/clipart2603846.png)
In collaboration with Assoc. Prof Marika Nestor (Uppsala University) the facilities of SciLifeLab's Drug Discovery and Development Platform, including the Human Antibody Therapeutics unit at the Dept. of Immunotechnology, have co-developed an antibody-based radiopharmaceutical intended for treatment of advanced thyroid cancer. The project now exits the SciLifeLab infrastructure environment for further commercial development.